GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer
NCT01176513
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
25
Enrollment
INDUSTRY
Sponsor class
Stopped
Lack of Subject enrollment
Conditions
Prostate Cancer
Interventions
DRUG:
GE-148 (18F)
Sponsor
GE Healthcare
Collaborators
[object Object]